Alesha Pennington, APRN
Family · London, KYNPI 1578849618
Payments from drug & device makers
Across 80 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aspira Women's Health Inc$359
- Bayer$210
- Mayne Pharma Commercial LLC$149
- Hologic Sales And Service, LLC$124
- AbbVie$122
- Astellas Pharma US Inc$90
- plus $629 from 20 others
What the payments were for
- Food & beverage$1,59195%
- Education$925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aspira Women's Health Inc | 6 | $359 |
| Bayer | 13 | $210 |
| Mayne Pharma Commercial LLC | 9 | $149 |
| Hologic Sales And Service, LLC | 7 | $124 |
| AbbVie | 7 | $122 |
| Astellas Pharma US Inc | 2 | $90 |
| Exeltis, USA Inc. | 4 | $63 |
| Sage Therapeutics, LLC | 3 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Organon | 3 | $55 |
| Exact Sciences | 3 | $46 |
| Shield Therapeutics Inc | 2 | $42 |
| Pfizer | 3 | $40 |
| Axonics, Inc. | 2 | $35 |
| Convatec Inc. | 1 | $35 |
| Avion Pharmaceuticals | 2 | $24 |
| Ortho-clinical Diagnostics, Inc. | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Millicent US Inc | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Gynesonics, Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $17 |
| Arjo Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Minerva Surgical, Inc | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$1,683 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 105 | $6,222 |
| Estradiol (Twice Weekly)Estradiol | 32 | $3,641 |
| ProgesteroneProgesterone, Micronized | 27 | $1,049 |
| Clobetasol Propionate | 36 | $483 |
| Medroxyprogesterone Acetate | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Other family in London
- Robin HouseLondon$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.